| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Meta-Analysis; Systematic Review; Journal Article
- Language: English
- [J Low Genit Tract Dis] 2024 Jan 01; Vol. 28 (1), pp. 76-83. <i>Date of Electronic Publication: </i>2023 Dec 07.
- MeSH Terms: Dequalinium* ; Vaginosis, Bacterial* / drug therapy ; Anti-Infective Agents* ; Anti-Infective Agents, Local* ; Candidiasis, Vulvovaginal* / drug therapy ; Vulvovaginitis* ; Female ; Humans ; Observational Studies as Topic
- References: Van Der Pol B. Diagnosing vaginal infections: it's time to join the 21st century. Curr Infect Dis Rep 2010;12:225–30. ; Petersen EE, Weissenbacher ER, Hengst P, et al. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study. Arzneimittelforschung 2002;52:706–15. ; Voytik M, Nyirjesy P. Cytolytic vaginosis: a critical appraisal of a controversial condition. Curr Infect Dis Rep 2020;22:26. ; Sobel JD. Vaginitis. N Engl J Med 1997;337:1896–903. ; Spinillo A, Capuzzo E, Gulminetti R, et al. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol 1997;176:138–41. ; CDC. Vulvovaginal candidiasis (VVC). Available at: https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm . Accessed August 16, 2022. ; Farr A. Vulvovaginalkandidose (Ausgenommen Chronisch Mukokutane Kandidose) . AWMF-Leitlinie; 2020. ; Foessleitner P, Kiss H, Deinsberger J, et al. Validation of the SavvyCheck™ vaginal yeast test for screening pregnant women for vulvovaginal candidosis: a prospective, cross-sectional study. J Fungi (Basel) 2021;7:233. ; Nyirjesy P, Brookhart C, Lazenby G, et al. Vulvovaginal candidiasis: a review of the evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis 2022;74:S162–s168. 2022/04/14. ; Bagnall P, Rizzolo D. Bacterial vaginosis: a practical review. Jaapa 2017;30:15–21. ; Larsson PG. A test of cure using a new molecular diagnostic approach for bacterial vaginosis in infected women treated with dequalinium chloride vaginal tablets. J Womens Health Gyn 2020;7:1–12. ; Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14–22. ; Ison CA, Hay PE. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 2002;78:413–5. 2002/12/11. ; AWMF. Sexuell übertragbare Infektionen (STI) – Beratung, Diagnostik und Therapie . Leitlinie; 2018. ; CDC. Bacterial vaginosis. Available at: https://www.cdc.gov/std/treatment-guidelines/bv.htm . Accessed August 16, 2022. ; Klebanoff MA, Schuit E, Lamont RF, et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: systematic review and individual participant data meta-analysis. Paediatr Perinat Epidemiol 2023;37:239–51. 20230118. ; Donders GG, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002;109:34–43. ; CDC. Sexually transmitted infections treatment guidelines. Available at: https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf . Accessed August 16, 2022. ; Foessleitner P, Kiss H, Deinsberger J, et al. Screening pregnant women for bacterial vaginosis using a point-of-care test: a prospective validation study. J Clin Med 2021;10:20210524. ; Farr A, Effendy I, Frey Tirri B, et al. Guideline: vulvovaginal candidosis (AWMF 015/072, level S2k). Mycoses 2021;64:583–602. doi:10.1111/myc.13248. (PMID: 10.1111/myc.13248) ; Hillier SL, Austin M, Macio I, et al. Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis 2021;72:1538–43. ; Della Casa V, Noll H, Gonser S, et al. Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections. Arzneimittelforschung 2002;52:699–705. ; Bailly C. Medicinal applications and molecular targets of dequalinium chloride. Biochem Pharmacol 2021;186:114467. 20210210. ; Brauss FW, Rieth H. Effectiveness of decamethylene aminoquinaldinium chloride against pathogenic microorganisms. MMW Munch Med Wochenschr 1974;116:1519–20. ; Hugo WB, Frier M. Mode of action of the antibacterial compound dequalinium acetate. Appl Microbiol 1969;17:118–27. ; Tischer M, Pradel G, Ohlsen K, et al. Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions? ChemMedChem 2012;7:22–31. 20111124. ; Gaspar C, Rolo J, Cerca N, et al. Dequalinium chloride effectively disrupts bacterial vaginosis (BV) Gardnerella spp. biofilms. Pathogens 2021;10:20210225. ; Antoni Vives J, Cancelo MJ, Losada M, et al. Dequalinium chloride use in adult Spanish women with bacterial vaginosis: an observational study. J Obstet Gynaecol 2022;42:103–9. 20210225. ; Donders G, Bellen G, Donders F, et al. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials. Eur J Clin Microbiol Infect Dis 2017;36:731–8. 20161208. ; Thamkhantho M, Chayachinda C. Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: a double-blind, randomized study. Arch Gynecol Obstet 2021;303:151–60. 20200917. ; Weissenbacher ER, Donders G, Unzeitig V, et al. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. Gynecol Obstet Invest 2012;73:8–15. 20111224. ; Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160. 20210329. ; Higgins JPTTJCJ, Cumpston M, Li T, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions . Chichester (UK): John Wiley & Sons; 2019. ; Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed June 16, 2022. ; Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419–25. ; AWMF. Bakterielle Vaginose. 2023. ; Vieira-Baptista PSC, Sobel J. International Society for the Study of Vulvovaginal Disease recommendations for the diagnosis and treatment of vaginitis. Admedic 2023; Available at: https://www.admedic.pt/uploads/issvd-recommendations-for-the-diagnosis-and-treatment-of-vaginitis_indice.pdf . Accessed September 21, 2023. ; Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol 2019;17:3. ; Martin JK 2nd, Sheehan JP, Bratton BP, et al. A dual-mechanism antibiotic kills Gram-negative bacteria and avoids drug resistance. Cell 2020;181:1518–1532.e1514. 20200603. ; Faught BM, Reyes S. Characterization and treatment of recurrent bacterial vaginosis. J Womens Health (Larchmt) 2019;28:1218–26. 20190812. ; Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2016;214:15–21. 20150709. ; Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it's associated resistance patterns. Microb Pathog 2019;127:21–30. 20181128. ; Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ 2019;97:548–562p. 20190606.
- Substance Nomenclature: E7QC7V26B8 (Dequalinium) ; 0 (Anti-Infective Agents) ; 0 (Anti-Infective Agents, Local)
- Entry Date(s): Date Created: 20231220 Date Completed: 20231222 Latest Revision: 20231226
- Update Code: 20231227
|
